您的位置：
首页
>
农业专利
>
详情页
DERIVES DE 2-(1,2,4-TRIAZOL-3-YLSULFANYL)-N-1,3,4-THIADIAZOL-2-YLE ACETAMIDE, UTILES POUR TRAITER, ENTRE AUTRES, LE DIABETE
- 专利权人:
- APOGLYX AB
- 发明人:
- RUTZLER, MICHAEL,BRIMERT, THOMAS,DREISCH, KLAUS,EVENAS, JOHAN,LARSSON, JOAKIM
- 申请号：
- CA2965873
- 公开号：
- CA2965873A1
- 申请日:
- 2015.10.28
- 申请国别(地区):
- CA
- 年份:
- 2016
- 代理人:
- 摘要：
- Disclosed are compounds, pharmaceutical compositions and methods for modulating aquaporin 9.
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
相关专利
- DERIVATIVES OF 2-(1,2,4-TRIAZOL-3-YLSULFANYL)-N-1,3,4-THIADIAZOL-2-YL ACETAMIDE WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA DIABETES
- Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes
- COMPOSITION FOR PROTEIN PHARMACEUTICAL PREPARATION WITH NO ADDED HUMAN SERUM ALBUMIN (HSA)
- Compound 6 - (1 - methyl - 1h-pyrazol-4-yl) - 3 - (2 - methyl - 5 - 2H - indazol iltio) - [1,2,4] triazole [4,3-b] pyridazine hydrochloride, Pharmaceutical composition Containing and use for preparing Medicine useful for treating cancer
- INHIBITEUR TRICYCLIQUE DE PI3K ET/OU MTOR
